About

I am an award-winning writer, editor, photographer and designer with more than 30 years of experience in the media. After studying at the University of Leeds, then London and Anglia HEC, I moved to Canada in the 1980s and started out on the radio while also writing for various music and sports publications, and doing freelance photography. I then edited some magazines before working at a science organization, doing communications and editing publications in a programming language called LaTeX that was challenging but exciting.

Following that, I edited a newspaper, spent some time in the US, and then moved back to the UK where I edited a food B2B publication.
I’ve written, and taken photographs for, hundreds of publications around the world, as well as for books, album covers, DVDs, and shot coverage for documentaries. I’ve edited books, written nine of my own, and done redesigns for several publications. And now I’m writing about biotech, as well as creating videos and a weekly podcast.

I’ve done other things, like running an aquarium, teaching photography and drumming (not at the same time), and running football (soccer) refereeing courses.

In what spare time I have, I love spending time with my wife, son and dog, challenging hikes up the Scottish hills (and down again), playing and writing music, watching baseball and soccer, and collecting memorabilia and autographs.

Articles by Jim Cornall

WuXi Biologics and Toregem BioPharma to develop antibody for adentia treatment

TILT Biotherapeutics doses first U.S. patient in ovarian cancer immunotherapy trial

Illumina and AstraZeneca look to drug target discovery with ‘pivotal research collaboration’

Gedea Biotech reports results from bacterial vaginosis trial

Muna Therapeutics gets $4.9M grant for Parkinson’s disease research

Positive results from NMD Pharma myasthenia gravis trial

ADVERTISEMENT

Clinical Microbiomics expanding with €10M million investment

Fast track designation for Nanoscope Therapeutics’ retinitis pigmentosa treatment

JW Therapeutics receives approval for relapsed or refractory follicular lymphoma drug

Evonik and Phathom Pharmaceuticals partner on novel acid-blocker vonoprazan

Biocartis starts European commercialization of liver cancer test

Chinese company sees approval for diabetes drug

ADVERTISEMENT